Blog - Page 18 of 5516 - QualityStocks

TuesdayDec 02, 2025 11:45 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Adopts Bitcoin Treasury Strategy With Initial Purchases Underway

Massimo Group (NASDAQ: MAMO) said its Board approved adding Bitcoin as part of a long-term treasury reserve strategy, with initial purchases already begun and holdings to be disclosed in upcoming SEC filings or via Form 8-K. The Company said the program will be funded primarily through operating cash flows, with the option to use market instruments, and will employ institutional-grade custody with multi-signature cold storage and audit-ready controls. Massimo expects Bitcoin to represent a single-digit percentage of total assets over five years, positioning it as a strategic reserve rather than an operating asset. CEO David Shan said the move reflects a…

TuesdayDec 02, 2025 11:19 am

QualityStocksNewsBreaks – GlobalTech Corp. (OTC: GLTK) Agrees to Acquire 51% of Moda in Pelle to Expand AI-Driven Retail and UK Market Reach

GlobalTech (OTC: GLTK), a U.S.-based technology holding company focused on AI, big data and emerging technologies, said it entered a definitive agreement to acquire a 51% interest in 123 Investments Limited d/b/a Moda in Pelle, a premium UK footwear brand with approximately $37 million in net revenue last year. The Company said the deal is expected to add a new revenue stream, strengthen its UK operational presence and enhance e-commerce capabilities through Thrivo AI integration, with closing expected within 30 days subject to customary conditions. CEO Dan Green said the acquisition aligns with GlobalTech’s value-creation strategy and will support…

TuesdayDec 02, 2025 11:15 am

Numa Numa Resources Inc. Positioned Amid Rising Geopolitical Interest

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Bougainville is home to the historic Panguna Mine, one of the world’s most valuable copper and gold deposits. The U.S. government has reached out to Bougainville in a notable move, with an invitation from ambassador-at-large B. Mark Walker to visit. Numa Numa Resources is positioned as one of the key private-sector entities working on long-term development in the region. Numa Numa Resources is operating in one of the most geopolitically significant mining regions in the world, and recent diplomatic developments suggest that Bougainville’s role in global resource…

TuesdayDec 02, 2025 11:01 am

QualityStocksNewsBreaks – Stewards Inc. (OTC: SWRD) Appoints Scott McGowan Chief Marketing Officer

Stewards (OTC: SWRD), a diversified financial company operating across private credit, real assets and digital finance, appointed Scott McGowan as chief marketing officer to lead integrated marketing and communications as the Company expands its operating segments and advances toward a planned Nasdaq Capital Market uplisting. McGowan, formerly director of investor relations at InvestorBrandNetwork and previously CEO of a strategic communications consultancy, brings more than 20 years of experience advising growth-stage companies on brand positioning, capital-markets strategy and stakeholder engagement. President Shaun Quin said McGowan will strengthen transparency and unify messaging as Stewards enters its next phase of growth. To view…

TuesdayDec 02, 2025 10:30 am

Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) Strengthens Canadian Critical Rare Earth Exploration with Award-Winning Geoscience Leadership

Disseminated on behalf of  Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) and may include paid advertising. Search Minerals focuses on important rare earth elements (“CREE”) exploration across Labrador, holding 100% interest in the Deep Fox and Foxtrot Projects Dr. Randy Miller, VP of Exploration and Chief Geologist, awarded the CIM Newfoundland and Labrador Geoscientist of the Year for decades of REE contributions The company’s Red Wine Cree and St. Lewis–Port Hope Simpson Districts host more than 20 prospects, strategically positioning Search Minerals as a pillar of Canada’s REE holdings Search Minerals (TSX.V: SMY) (OTC: SHCMF) is a critical exploration and…

TuesdayDec 02, 2025 9:50 am

QualityStocksNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Adds Insurance and Employer-Benefits Leaders Chris Pulos and Jason Bishara to Board

HealthLynked (OTCQB: HLYK), an AI-driven global healthcare network focused on improving care coordination and reducing costs, appointed Chris G. Pulos of Marsh McLennan Agency and Jason Bishara of NSI Insurance Group to its Board. The Company said the additions bring decades of experience in employer benefits, payer strategy, insurance and risk management as HealthLynked expands collaborations with insurers, employer groups and healthcare organizations. Founder and CEO Dr. Michael Dent said their expertise will support national scaling of the HealthLynked Network and its AI platform, ARI, while strengthening governance ahead of a planned Nasdaq Capital Market listing. To view the full…

TuesdayDec 02, 2025 9:45 am

OptimumBank Holdings Inc. (NYSE American: OPHC) Posts Higher Earnings, Loan Growth, and Expanding Deposits in Q3 2025

OptimumBank reported Q3 2025 net earnings of $4.32 million, an increase from both the prior quarter and the same period last year. Total deposits grew 9.17% from Q2 and nearly 19% year-over-year, reaching $959.49 million. Loans expanded during the quarter, driven by growth in commercial real estate and consumer lending. Net interest margin rose to 4.37%, supported by higher asset yields and improved funding costs. Leadership emphasized continued growth, strong capital levels, and a community-banking model centered on relationship banking. OptimumBank Holdings (NYSE American: OPHC), a bank holding company that owns 100% of community bank OptimumBank, headquartered in Fort Lauderdale,…

TuesdayDec 02, 2025 9:30 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) JV Sapu Nano Presents Data Showing Deciparticle Platform Supports Broad Hydrophobic Drug Formulation

Oncotelic Therapeutics (OTCQB: OTLC) said its 45%-owned joint venture, Sapu Nano, reported new data at the 2025 San Antonio Breast Cancer Symposium showing that its Deciparticle(TM) nanomedicine platform can consistently formulate structurally diverse hydrophobic therapeutics—including macrolide mTOR inhibitors, cyclic and linear peptides, ascomycin macrolactams and polyketides—into sub-20 nm nanoparticles suitable for IV delivery. The Company said the findings confirm Deciparticle as a versatile, cGMP-ready delivery platform backed by ISO-5 manufacturing capabilities that support rapid translation to Phase 1 supply. CEO Dr. Vuong Trieu said the results position Deciparticle as a modular engine for multiple oncology, immunology and peptide drug candidates,…

TuesdayDec 02, 2025 9:20 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said the FDA has received its Abbreviated New Drug Application for KETAFREE(TM), a preservative-free intravenous ketamine formulation, deeming the submission “substantially complete” and assigning a July 29, 2026 review goal date. CEO Jonathan Javitt said KETAFREE is designed to provide a single-patient, preservative-free alternative to current multidose ketamine vials that contain Benzethonium Chloride, a compound no longer recognized as safe by the FDA. The Company said KETAFREE aligns with MAHA initiatives to remove toxic substances from medicines and supports domestic supply-chain priorities, with potential 2026 approved drug sales if approved on schedule.…

TuesdayDec 02, 2025 9:10 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for Dec. 2

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it will host a corporate update conference call on Dec. 2, 2025, at 9 a.m. Eastern to review recent clinical, regulatory and operational developments. To view the full press release, visit https://ibn.fm/9WZCK About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc. (www.nrxpharma.com), is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. The Company is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal…

Site Search

Company Search